Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | -10.00% | -3.95% | +24.09% |
Financials (USD)
Sales 2022 | 2.38M | Sales 2023 | - | Capitalization | 10.25M |
---|---|---|---|---|---|
Net income 2022 | -50M | Net income 2023 | -65M | EV / Sales 2022 | 21.8 x |
Net cash position 2022 | 5.73M | Net Debt 2023 | 13.17M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.14
x | P/E ratio 2023 |
-0.11
x | Employees | 26 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.82% |
Latest transcript on iBio, Inc.
1 week | +0.53% | ||
Current month | -53.20% | ||
1 month | +74.31% | ||
3 months | +65.22% | ||
6 months | -66.90% | ||
Current year | +38.69% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Brenner
CEO | Chief Executive Officer | 54 | 21-01-17 |
Felipe Duran
DFI | Director of Finance/CFO | 45 | 21-03-31 |
Phan Dillon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chip Clark
CHM | Chairman | 56 | 21-08-22 |
Linda Armstrong
BRD | Director/Board Member | 61 | 20-10-13 |
Gary Sender
BRD | Director/Board Member | 62 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.7 | -10.53% | 196 933 |
24-04-24 | 1.9 | 0.00% | 99,189 |
24-04-23 | 1.9 | +6.74% | 167,580 |
24-04-22 | 1.78 | +3.49% | 103,682 |
24-04-19 | 1.72 | -2.82% | 95,388 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+38.69% | 16.36M | |
+25.61% | 660B | |
+23.28% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+13.17% | 219B | |
-9.45% | 196B | |
+6.70% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- IBIO Stock